Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator

Journal of Cell Science

Volumn 121, Issue 17, 2008, Pages 2814-2823

  Chang, Xiu Bao ^a   Mengos, April ^a   Hou, Yue Xian ^a   Cui, Liying ^b   Jensen, Timothy J ^b   Aleksandrov, Andrei ^b,c   Riordan, John R ^b   Gentzsch, Martina ^b,d  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Calnexin; CFTR; EDEM; Glycoprotein; Glycosylation; Processing

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; CALNEXIN; CHLORIDE CHANNEL; LECTIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUNICAMYCIN;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL MEMBRANE; CONTROLLED STUDY; DEGLYCOSYLATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CALNEXIN; CELL LINE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HUMANS; LECTINS; MODELS, BIOLOGICAL; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTANT PROTEINS; OLIGOSACCHARIDES; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT;

EID: 53349151733     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.028951     Document Type: Article

References (87)

1. Aleksandrov, A. A. and Riordan, J. R. (1998). Regulation of CFTR ion channel gating by MgATP. FEBS Lett. 431, 97-101.
2. Amaral, M. D. and Kunzelmann, K. (2007). Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis. Trends Pharmacol. Sci. 28, 334-341.
3. Appenzeller-Herzog, C. and Hauri, H. P. (2006). The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function. J. Cell Sci. 119, 2173-2183.
4. Appenzeller, C., Andersson, H., Kappeler, F. and Hauri, H. P. (1999). The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nat. Cell Biol. 1, 330-334.
5. Brothers, S. P., Janovick, J. A. and Conn, P. M. (2006). Calnexin regulated gonadotropi-releasing hormone receptor plasma membrane expression. J. Mol. Endocrinol. 37, 479-488.
6. Chang, X.-B., Hou, Y.-X., Jensen, T. and Riordan, J. R. (1994). Mapping of the Cystic Fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion. J. Biol. Chem. 269, 18572-18575.
7. Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'Riordan, C. R. and Smith, A. E. (1990). Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827-834.
8. Chow, D. C. and Forte, J. G. (1995). Functional significance of the beta-subunit for heterodimeric P-type ATPases. J. Exp. Biol. 198, 1-17.
9. Coyne, C. B., Kelly, M. M., Boucher, R. C. and Johnson, L. G. (2000). Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am. J. Respir. Cell Mol. Biol. 23, 602-609.
10. Cruciat, C. M., Hassler, C. and Niehrs, C. (2006). The N4RH protein Erlectin is a member of the endoplasmic reticulum synexpression group and functions in N-glycan recognition. J. Biol. Chem. 281, 12986-12993.
11. Dalemans, W., Barbry, P., Champigny, G., Jallat, S., Dott, K., Dreyer, D., Crystal, R. G., Pavarani, A., Lecocq, J.-P. and Lazdunski, M. (1991). Altered chloride ion channel kinetics associated with the DeltaF508 cystic fibrosis mutation. Nature 354, 526-528.
12. de Souza, N. F. and Simon, S. M. (2002). Glycosylation affects the rate of traffic of the Shaker potassium channel through the secretory pathway. Biochemistry 41, 11351-11361.
13. Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E. and Welsh, M. J. (1992). Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764.
14. Dickson, K. M., Bergeron, J. J., Shames, I., Colby, J., Nguyen, D. T., Chevet, E., Thomas, D. Y. and Snipes, G. J. (2002). Association ofcalnexin with mutant peripheral myelin protem-22 ex vivo: a basis for "gain-of-function" ER diseases. Proc. Natl. Acad. Sci. USA 99, 9852-9857.
15. Diop, N. K. and Hrycyna, C. A. (2005). N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane. Biochemistry 44, 5420-5429.
16. Dragomir, A., Bjorstad, J., Hjelte, L. and Roomans, G. M. (2004). Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells. Biochem. Biophys. Res. Commun. 322, 447-451.
17. Drumm, M. L., Wilkinson, D. J., Smit, L. S., Worrell, R. T., Strong, T. V., Frizzell, R. A., Dawson, D. C. and Collins, F. S. (1991). Chloride conductance expressed by Delta F508 and other mutant CFTRs in Xenopus oocytes. Science 254, 1797-1799.
18. Egan, M. E., Glockner-Pagel, J., Ambrose, C., Cahill, P. A, Pappoe, L., Balamuth, N., Cho, E., Canny, S., Wagner, C. A., Geibel, J. et al. (2002). Calcium-purnp, inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat. Med. 8, 485-492.
19. Egan, M. E., Pearson, M., Weiner, S. A., Rajendran, V., Rubin, D., Glockner-Pagel, J., Canny, S., Do, K., Lukacs, G. L. and Caplan, M. J. (2004). Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304, 600-602.
20. Elbein, A. D., Tropea, J. E., Mitchell, M. and Kaushal, G. P. (1990). Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I. J. Biol. Chem. 265, 15599-15605.
21. Farinha, C. M. and Amaral, M. D. (2005). Most F508det-CFTR is targeted to degradation at an early folding checkpoint and independently of cahlexin. Mol. Cell. Biol. 25, 5242-5252.
22. Fuhrmann, U., Bause, E., Legler, G. and Ploegh, H. (1984). Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides. Nature 307, 755-758.
23. Fulcher, M. L., Gabriel, S., Burns, K. A., Yankaskas, J. R. and Randell, S. H. (2005). Well-differentiated human airway epithelial cell cultures. In Methods in Molecular Medicine: Human Cell Culture Protocols, vol. 107 (ed. J. Picot), pp. 183-206. Totowa, NJ: Humana Press.
24. Gentzsch, M., Chang, X. B., Cui, L., Wu, Y., Ozols, V. V., Choudhury, A., Pagano, R. E. and Riordan, J. R. (2004). Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol. Biol. Cell 15, 2684-2696.
25. Gnann, A., Riordan, J. R. and Wolf, D. H. (2004). Cystic fibrosis transmembrane conductance regulator degradation depends on the lectins Htm1p/EDEM and the Cdc48 protein complex in yeast. Mol. Biol. Cell 15, 4125-4135.
26. Gregory, R. J., Rich, D. P., Cheng, S. H., Souza, D. W., Paul, S., Manavalan, P., Anderson, M. P., Welsh, M. I. and Smith, A. E. (1991). Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol. Cell. Biol. 11, 3886-3893.
27. Gribar, J. J., Ramachandra, M., Hrycyna, C. A., Dey, S. and Ambudkar, S. V. (2000). Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system. J. Membr. Biol. 173, 203-214.
28. Grubb, B. R., Gabriel, S. E., Mengos, A., Gentzsch, M., Randell, S. H., Van Heeckeren, A. M., Knowles, M. R., Drumm, M. L., Riordan, J. R. and Boucher, R. C. (2006). SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 34, 355-363.
29. Halaban, R., Svedine, S., Cheng, E., Smicun, Y., Aron, R. and Hebert, D. N. (2000). Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism. Proc. Natl. Acad. Sci. USA 97, 5889-5894.
30. Harada, K., Okiyoneda, T., Hashimoto, Y., Oyokawa, K., Nakamura, K., Suico, M. A., Shuto, T. and Kai, H. (2007). Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulin. Biochem. Biophys. Res. Commun. 353, 351-356.
31. Hebert, D. N., Zhang, J. X., Chen, W., Foellmer, B. and Helenius, A. (1997). The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J. Cell Biol. 139, 613-623.
32. Helenius, A. and Aebi, M. (2001). Intracellular functions of N-linked glycans. Science 291, 2364-2369.
33. Hendriks, G., Koudijs, M., van Balkom, B. W., Oorschot, V., Klumperman, J., Deen, P. M. and van der Sluijs, P. (2004). Glycosylation is important for cell surface expression of the water channel aquaporin-2 but is not essential for tetramerization in the endoplasmic reticulum. J. Biol. Chem. 279, 2975-2983.
34. Hirsch, C., Blom, D. and Ploegh, H. L. (2003). A role for N-glycanase in the cytosolic turnover of glycoproteins. EMBO J. 22, 1036-1046.
35. Hirsch, C., Misaghi, S., Blom, D., Pacold, M. E. and Ploegh, H. L. (2004). Yeast N-glycanase distinguishes between native and non-native glycoproteins. EMBO Rep. 5, 201-206.
36. Imperiali, B. and Hendrickson, T. L. (1995). Asparagine-linked glycosylation: specificity and function of oligosaccharyl transferase. Bioorg. Med. Chem. 3, 1565-1578.
37. Jackson, M. R., Cohen-Doyle, M. F., Peterson, P. and Williams, D. B. (1994). Regulation of MHC Class I transport by the molecular chaperone, calnexin (p88, IP90). Science 263, 384-387.
38. Jensen, T. J., Loo, M. A., Pind, S., Williams, D. B., Goldberg, A. L. and Riordan, J. R. (1995). Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83, 129-135.
39. Joshi, S., Katiyar, S. and Lennarz, W. J. (2005). Misfolding of glycoproteins is a prerequisite for peptide: N-glycanase mediated deglycosylation. FEBS Lett. 579, 823-826.
40. Kostova, Z. and Wolf, D. H. (2005). Importance of carbohydrate positioning in the recognition of mutated CPY for ER-associated degradation. J. Cell Sci. 118, 1485-1492.
41. Kramer, R., Weber, T. K., Arceci, R., Ramchurren, N., Kastrinakis, W. V., Steele, G., Jr and Summerhayes, I. C. (1995). Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype. Br. J. Cancer 71, 670-675.
42. Kreda, S. M., Mall, M., Mengos, A., Rochelle, L., Yankaskas, J., Riordan, J. R. and Boucher, R. C. (2005). Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol. Biol. Cell 16, 2154-2167.
43. Li, J. G., Chen, C. and Lin-Chen, L. Y. (2007). N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway. Biochemistry 46, 10960-10970.
44. Loo, T. W., Bartlett, M. C. and Clarke, D. M. (2004). Thapsigargin or curcumin does not promote maturation of processing mutants of the ABC transporters, CFTR, and P-glycoprotein. Biochem. Biophys. Res. Commun. 325, 580-585.
45. Loo, T. W., Bartlett, M. C. and Clarke, D. M. (2005). Rescue of folding defects in ABC transporters using pharmacological chaperones. J. Bioenerg. Biomembr. 37, 501-507.
46. Lu, M., Echeverri, F. and Moyer, B. D. (2003). Endoplasmic reticulum retention, degradation, and aggregation of olfactory G-protein coupled receptors. Traffic 4, 416-433.
47. Lukacs, G. L., Mohamed, A., Kartner, N., Chang, X.-B., Riordan, J. R. and Grinstein, S. (1994). Conformational maturation of CFTR but not its mutant counterpart (DeltaF508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 13, 6076-6086.
48. Mohrmann, K., van Eijndhoven, M. A., Schinkel, A. H. and Schellens, J. H. (2005). Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ ABCG2). Cancer Chemother Pharmacol. 56, 344-350.
49. Molinari, M., Eriksson, K. K., Calanca, V., Galli, C., Cresswell, P., Michalak, M. and Helenius, A. (2004). Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control. Mol. Cell 13, 125-135.
50. Morello, J. P., Salahpour, A., Petaja-Repo, U. E., Laperriere, A., Lonergan, M., Arthus, M. F., Nabi, I. R., Bichet, D. G. and Bouvier, M. (2001). Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus. Biochemistry 40, 6766-6775.
51. Morris, A. P., Cunningham, S. A., Benos, D. J. and Frizzell, R. A. (1993). Glycosylation status of endogenous CFTR does not affect cAMP-stimulated Cl - secretion in epithelial cells. Am. J. Physiol. 265, C688-C694.
52. Nagaya, N., Schulteis, C. T. and Papazian, D. M. (1999). Calnexin associates with Shaker K+ channel protein but is not involved in quality control of subunit folding or assembly. Recept. Channels 6, 229-239.
53. Neve, E. P., Svensson, K., Fuxe, J. and Pettersson, R. F. (2003). VIPL, a VIP36-like membrane protein with a putative function in the export of glycoproteins from the endoplasmic reticulum. Exp. Cell Res. 288, 70-83.
54. Norez, C., Antigny, F., Becq, F. and Vandebrouck C. (2006a). Maintaining low Ca2+ level in the endoplasmic reticulum restores abnormal endogenous F508del-CFTR trafficking in airway epithelial cells. Traffic 7, 562-573.
55. Norez, C., Noel, S., Wilke, M., Bijvelds, M., Jorna, H., Melia, P., Dejonge, H. and Becq, F. (2006b). Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat. FEBS Lett. 580, 2081-2086.
56. Oda, Y., Hosokawa, N., Wada, I. and Nagata, K. (2003). EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science 299, 1394-1397.
57. Oda, Y., Okada, T., Yoshida, H., Kaufman, R. J., Nagata, K. and Mori, K. (2006). Derlin-2 and Derfin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation. J. Cell Biol. 172, 383-393.
58. Okiyoneda, T., Wada, I., Joino, H., Shuto, T., Yoshitake, K., Nakano, N., Nagayama, S., Harada, K., Isohama, Y., Miyata, T. et al. (2002). Calnexin Delta 185-520 partially reverses the misprocessing of the Delta F508 cystic fibrosis transmernbrane conductance regulator. FEBS Lett. 526, 87-92.
59. Okiyoneda, T., Harada, K., Takeya, M., Yamahira, K., Wada, I., Shuto, T., Suico, M. A., Hashimoto, Y. and Kai, H. (2004). Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression. Mol. Biol. Cell 15, 563-574.
60. Okiyoneda, T., Niibori, A., Harada, K., Kohno, T., Michalak, M., Duszyk, M., Wada, I., Ikawa, M., Shuto, T., Suico, M. A. et al. (2008). Role of calnexin in the ER quality control and productive folding of CFTR; differential effect of calnexin knockout on wild-type and Deltal508 CFTR. Biochim. Biophys. Acta 9, 1585-1594.
61. Paredes, A., Plata, C., Rivera, M., Moreno, E., Vazquez, N., Munoz-Clares, R., Hebert, S. C. and Gamba, G. (2006). Activity of the renal Na+-K+-2Cl - cotransporter is reduced by mutagenesis of N-glycosylation sites: role for protein surface charge in Cl - transport. Am. J. Physiol. Renal Physiol. 290, F1 094-F1102.
62. Parodi, A. J. (2000). Protein glucosylation and its role in protein folding. Annu. Rev. Biochem. 69, 69-93.
63. Pedemonte, N., Lukacs, G. L., Du, K., Caci, E., Zegarra-Moran, O., Galietta, L. J. and Verkman, A. S. (2005). Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J. Clin. Invest. 115, 2564-2571.
64. Pind, S., Riordan, J. R. and Williams, D. B. (1994). Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogeriesis of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269, 12784-12788.
65. Potter, B. A., Ihrke, G., Bruns, J. R., Weixel, K. M. and Weisz, O. A. (2004). Specific N-glycans direct apical delivery of transmembrane, but not soluble or glycosylphosphatidylinositol-anchored forms of endolyn in Madin-Darby canine kidney cells. Mol. Biol. Cell 15, 1407-1416.
66. Rajagopalan, S. and Brenner, M. B. (1994). Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the endoplasmic reticulum. J. Exp. Med. 180, 407-412.
67. Rigot, V., Andre, F., Lehmann, M., Lissitzky, J. C., Marvaldi, J. and Luis, J. (1999). Biogenesis of alpha6beta4 integrin in a human colonic adenocarcinoma cell line involvement of calnexin. Eur. J. Biochem. 261, 659-666.
68. Riordan, J. R. (2008). CFTR Function and Prospects for Therapy. Annu. Rev. Biochem. 77, 701-726.
69. Sasak, V. W., Ordovas, J. M., Elbein, A. D. and Berninger. R. W. (1985). Castanospermine inhibits glucosidase I and glycoprotein secretion in human hepatoma cells. Biochem. J. 232, 759-766.
70. Schinkel, A. H., Kemp, S., Dolle, M., Rudeako, G. and Wagenaar, E. (1993). N-glycosylation and deletion mutants ofthe human MDR1 P-glycoprotein. J. Biol. Chem. 268, 7474-7481.
71. Sharma, M., Pampinella, F., Nemes, C., Benharouga, M., So, J., Du, K., Bache, K. G., Papsin, B., Zerangue, N., Stenmark, H. et al. (2004). Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. J. Cell Biol. 164, 923-933.
72. Shimada, O., Hara-Kuge, S., Yamashita, K., Tosaka-Shimada, H., Yanchao, L., Yongnan, L., Atsumi, S. and Ishikawa, H. (2003). Clusters of VIP-36-positive vesicles between endoplasmic reticulum and Golgi apparatus in GH3 cells. Cell Struct. Funct. 28, 155-163.
73. Slominska-Wojewodzka, M., Gregers, T. F., Walchli, S. and Sandvig, K. (2006). EDEM is involved in retrotranslocation of ricin from the endoplasmic reticutum to the cytosol. Mol. Biol. Cell 17, 1664-1675.
74. Song, Y., Sonawane, N. D., Salinas, D., Qian, L., Pedemonte, N., Galietta, L. J. V. and Verkman, A. S. (2004). Evidence against the rescue of defective deltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. J. Biol. Chem. 279, 40629-40633.
75. Spear, E. D. and Ng, D. T. (2005). Single, context-specific glycans can target misfolded glycoproteins for ER-associated degradation. J. Cell Biol. 169, 73-82.
76. Standley, S. and Baudry, M. (2000). The role of glycosylation in ionotropic glutamate receptor ligand binding, function, and trafficking. Cell. Mol. Life Sci. 57, 1508-1516.
77. Suzuki, T. and Lennarz, W. J. (2003). Hypothesis: a glycoprotein-degradation complex formed by protein-protein interaction involves cytoplasmic peptide: N-glycanase. Biochem. Biophys. Res. Commun. 302, 1-5.
78. Urbatsch, I. L., Wilke-Mounts, S., Gimi, K. and Senior, A. E. (2001). Purification and characterization of N-glycosylation mutant mouse and human P-glycoproteins expressed in Pichia pastoris cells. Arch. Biochem. Biophys. 388, 171-177.
79. Vagin, O., Turdikulova, S. and Sachs, G. (2004). The H,K-ATPase beta subunit as a model to study the role of N-glycosylation in membrane trafficking and apical sorting. J. Biol. Chem. 279, 39026-39034.
80. Vagin, O., Turdikulova, S. and Tokhtaeva, E. (2007). Polarized membrane distribution of potassium-dependent ion pumps in epithelial cells: different roles of the N-glycans of their beta subunits. Cell Biochem. Biophys. 47, 376-391.
81. Van Goor, F., Straley, K. S., Cao, D., Gonzalez, J., Hadida, S., Hazlewood, A., Joubran, J., Knapp, T., Makings, L. R., Miller, M. et al. (2006). Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L1117-L1130.
82. Wang, X., Venable, J., LaPointe, P., Hutt, D. M., Koulov, A. V., Coppinger, J., Gurkan, C., Kellner, W., Matteson, J., Plutner, H. et al. (2006). Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127, 803-815.
83. Ward, C. L. and Kopito, R. R. (1994). Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J. Biol. Chem. 269, 25710-25718.
84. Ward, C. L., Omura, S. and Kopito, R. R. (1995). Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121-127.
85. Younger, J. M., Chen, L., Ren, H. Y., Rosser, M. R, Tbrnbull, E. L., Fan, C. Y., Patterson, C. and Cyr, D. M. (2006). Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126, 571-582.
86. Zhang, J. X., Braakman, I., Matlack, K. E. and Helenius, A. (1997). Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations. Mol. Biol. Cell 8, 1943-1954.
87. Zhang, Z., Wu, J. Y., Hait, W. N. and Yang, J. M. (2004). Regulation of the stability of P-glycoprotein by ubiquitination. Mol. Pharmacol. 66, 395-403.